Budget Impact Analysis of Switching to Darunavir/Ritonavir Monotherapy for HIV-Infected People in Spain

Juan Pasquau, Joana Gostkorzewicz, Francisco Ledesma, Anne Anceau, Andrew Hill and Christiane Moecklinghoff
Additional contact information
Juan Pasquau: Hospital Virgen de las Nieves, Granada, Spain
Joana Gostkorzewicz: Janssen, Madrid, Spain
Francisco Ledesma: Janssen, Madrid, Spain
Anne Anceau: Janssen, Issy-les-Moulineaux, France
Andrew Hill: MetaVirology Ltd, London, UK
Christiane Moecklinghoff: Janssen, Neuss, Germany

Applied Health Economics and Health Policy, 2012, vol. 10, issue 2, pages 139-141

Keywords: Antiretrovirals; Budget-impact-analysis; Darunavir/ritonavir; HIV-infections (search for similar items in EconPapers)
JEL-codes: C D I Z I1 I19 I18 I11 (search for similar items in EconPapers)
Date: 2012
References: Add references at CitEc
Citations Track citations by RSS feed

Downloads: (external link)
http://healtheconomics.adisonline.com/pt/re/ahe/pd ... -201210020-00006.pdf (application/pdf)
http://healtheconomics.adisonline.com/pt/re/ahe/fu ... -201210020-00006.htm (text/html)
Pay per view

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: http://EconPapers.repec.org/RePEc:wkh:aheahp:v:10:y:2012:i:2:p:139-141

Access Statistics for this article

Applied Health Economics and Health Policy is edited by Tim Wrightson

More articles in Applied Health Economics and Health Policy from Springer Healthcare | Adis
Series data maintained by Dave Dustin ().